Recent Updates
Recently added Catalysts
CNTN Positive Sentiment Score: 75/100

Tharimmune, Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer Leadership Expansion Supports Execution of Canton Network Infrastructure Strategy Former DRW and Citadel Le

Key Takeaway: Tharimmune, Inc. has appointed Mark Wendland as Chairman of the Board and Angela Radkowski as Chief Operating Officer, effective February 5, 2026. This leadership expansion aims to support the execution of the company's Canton Network strategy, which seeks to modernize financial market infrastructure using Canton Coin. Wendland and Radkowski bring significant industry experience and are expected to drive institutional adoption of the Canton Network, thereby enhancing shareholder value. The company focuses on bridging traditional financial markets with digital asset capabilities.

Market Sentiment Analysis

POSITIVE FACTORS

  • Mark Wendland's appointment as Chairman signifies strong leadership continuity.
  • Angela Radkowski's extensive experience is expected to enhance operational capabilities.
  • The strategic focus on institutional adoption of the Canton Network indicates growth potential.

Full Press Release Details

Inc. Appoints Mark Wendland Chairman of the Board and Names Angela Radkowski Chief Operating Officer
Expansion Supports Execution of Canton Network Infrastructure Strategy
DRW and Citadel Leader Joins as COO to Drive Institutional Platform Expansion
YORK, February 6, 2026 - Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company"), the first publicly
traded company to leverage Canton Coin ("CC") to support the Canton Network's ability to digitize traditional financial
markets, today announced that its Board of Directors (the "Board") has elected Mark Wendland, Chief Executive Officer, as
Chairman of the Board and approved the appointment of Angela Radkowski as Chief Operating Officer, effective February 5, 2026. Mr. Wendland
succeeds Vincent LoPriore, who will transition to a member of the Board after serving as Chairman since May 9, 2025.
her role as COO, Ms. Radkowski will oversee operational control functions and enterprise processes, including the implementation of Tharimmune's
Canton Network quarterly research initiative and Super Validator activation.
am honored to assume the role of Chairman as we continue executing on our Canton Network-aligned digital asset strategy to help modernize
financial market infrastructure," said Mark Wendland. "The Board, under the dedicated leadership of Vincent LoPriore, has
demonstrated an unwavering commitment to building a governance and operating structure capable of supporting our digital asset treasury
strategy, and Angela's appointment adds critical leadership at a pivotal moment. Her experience scaling complex financial systems
will be instrumental as we advance institutional adoption of Canton Network and drive value for shareholders."
to her appointment, Ms. Radkowski served as Operations Strategy Lead and Chief of Staff to the Chief Operating Officer at DRW Holdings
LLC, advising senior leadership, coordinating cross-functional communication, and managing high-priority, enterprise-level initiatives.
Ms. Radkowski previously held positions within Citadel LLC's Treasury and Engineering organizations, where she was responsible
for coordinating enterprise deliverables involving optimization, data engineering, and technology upgrades.
Radkowski added, "The Canton Network introduces a new model for institutional finance - one that addresses the limitations
of legacy infrastructure while enabling secure, scalable blockchain adoption. I am excited to join Tharimmune and help build the operational
foundation required to support this transformation."
established its differentiated digital asset treasury strategy in November 2025. In addition to driving value through CC acquisition
and operating as a Super Validator, Tharimmune intends to invest in applications built on the Canton Network that accelerate institutional
utility and adoption across capital markets. Tharimmune is the first and only publicly traded company supported by the Canton Foundation.
Inc. (NASDAQ: THAR) is the first publicly traded company to leverage Canton Coin and support the Canton Network to advance institutional
blockchain adoption and the digitization of financial markets. In addition to driving value through activities on the Canton Network,
Tharimmune also operates clinical-stage biotech research and development. For more information, visit: www.tharimmune.com.
Note Regarding Forward-Looking Statements
press release contains statements that constitute "forward-looking statements" within the meaning of U.S. federal securities
laws. Forward-looking statements are statements other than historical facts and include, without limitation, those regarding management
expectations, strategy execution, market conditions, and the Company's involvement with the Canton Network. These statements are
based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Further information
regarding factors that may affect the Company's prospects is included in its annual and quarterly reports filed with the U.S. Securities
and Exchange Commission, available at www.sec.gov. The Company undertakes no obligation to update these statements except as required

Frequently Asked Questions

Who is the new Chairman of Tharimmune, Inc.?

Mark Wendland has been appointed as the Chairman of Tharimmune's Board.

What role will Angela Radkowski serve at Tharimmune?

Angela Radkowski is appointed Chief Operating Officer to lead operational functions.

What is the focus of Tharimmune's Canton Network strategy?

Tharimmune aims to modernize financial markets using the Canton Network.

What experience does Angela Radkowski bring to Tharimmune?

She has extensive experience in financial system operations from previous roles.

What is unique about Tharimmune in the market?

Tharimmune is the first publicly traded company utilizing Canton Coin for blockchain.

Last updated: Feb 6, 2026